Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have received an average rating of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a buy rating and one has given a strong buy […]
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have received an average rating of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a buy rating and one has given a strong buy […]
